Hikma Pharmaceuticals PLC (HKMPF)
OTCMKTS
· Delayed Price · Currency is USD
27.51
0.00 (0.00%)
At close: Mar 10, 2025
Hikma Pharmaceuticals Revenue
In the year 2024, Hikma Pharmaceuticals had annual revenue of $3.13B with 8.77% growth. Hikma Pharmaceuticals had revenue of $1.56B in the half year ending December 31, 2024, with 19.48% growth.
Revenue
3.13B
Revenue Growth
+8.77%
P/S Ratio
n/a
Revenue / Employee
329.16K
Employees
9,500
Market Cap
5.79B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.13B | 252.00M | 8.77% |
Dec 31, 2023 | 2.88B | 358.00M | 14.22% |
Dec 31, 2022 | 2.52B | -36.00M | -1.41% |
Dec 31, 2021 | 2.55B | 212.00M | 9.06% |
Dec 31, 2020 | 2.34B | 134.00M | 6.07% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 43.26M |
BioStem Technologies | 210.49M |
Hikma Pharmaceuticals News
- 15 days ago - Hikma Pharmaceuticals PLC (HKMPF) Q4 2024 Earnings Call Pre-Recorded (Transcript) - Seeking Alpha
- 16 days ago - Hikma Pharmaceuticals reports FY results - Seeking Alpha
- 2 months ago - Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg - Benzinga
- 2 months ago - Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 mg - PRNewsWire
- 7 months ago - Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices - Benzinga
- 7 months ago - Hikma Pharmaceuticals participates in naloxone training event with U.S. Congressman Buddy Carter ahead of National Fentanyl Awareness and Prevention Day - PRNewsWire
- 7 months ago - KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 months - Benzinga
- 7 months ago - KLOXXADO® 8mg Naloxone Nasal Spray Shelf-Life Extended from 24 months to 36 months - PRNewsWire